Retinoic Acid, GABA-ergic, and TGF-beta Signaling Systems Are Involved in Human Cleft Palate Fibroblast Phenotype
Overview
Molecular Biology
Authors
Affiliations
During embryogenesis, a complex interplay between extracellular matrix (ECM) molecules, regulatory molecules, and growth factors mediates morphogenetic processes involved in palatogenesis. Transforming growth factor-beta (TGF-beta), retinoic acid (RA), and gamma-aminobutyric acid (GABA)ergic signaling systems are also potentially involved. Using [3H]glucosamine and [35S]methionine incorporation, anion exchange chromatography, semiquantitative radioactive RT-PCR, and a TGF-beta binding assay, we aimed to verify the presence of phenotypic differences between primary cultures of secondary palate (SP) fibroblasts from 2-year-old subjects with familial nonsyndromic cleft lip and/or palate (CLP-SP fibroblasts) and age-matched normal SP (N-SP) fibroblasts. The effects of RA--which, at pharmacologic doses, induces cleft palate in newborns of many species--were also studied. We found an altered ECM production in CLP-SP fibroblasts that synthesized and secreted more glycosaminoglycans (GAGs) and fibronectin (FN) compared with N-SP cells. In CLP-SP cells, TGF-beta3 mRNA expression and TGF-beta receptor number were higher and RA receptor-alpha (RARA) gene expression was increased. Moreover, we demonstrated for the first time that GABA receptor (GABRB3) mRNA expression was upregulated in human CLP-SP fibroblasts. In N-SP and CLP-SP fibroblasts, RA decreased GAG and FN secretion and increased TGF-beta3 mRNA expression but reduced the number of TGF-beta receptors. TGF-beta receptor type I mRNA expression was decreased, TGF-beta receptor type II was increased, and TGF-beta receptor type III was not affected. RA treatment increased RARA gene expression in both cell populations but upregulated GABRB3 mRNA expression only in N-SP cells. These results show that CLP-SP fibroblasts compared with N-SP fibroblasts exhibit an abnormal phenotype in vitro and respond differently to RA treatment, and suggest that altered crosstalk between RA, GABAergic, and TGF-beta signaling systems could be involved in human cleft palate fibroblast phenotype.
Functional variant at 19q13.3 confers nonsyndromic cleft palate susceptibility by regulating .
Lou S, Miao Z, Li X, Ma L, Li D, Du M iScience. 2025; 28(2):111829.
PMID: 39967876 PMC: 11834074. DOI: 10.1016/j.isci.2025.111829.
Pereira J, Melo S, Ferreira R, Carneiro P, Yang V, Maia A Cell Commun Signal. 2024; 22(1):152.
PMID: 38414029 PMC: 10898076. DOI: 10.1186/s12964-024-01532-x.
An improved multicellular human organoid model for the study of chemical effects on palatal fusion.
Wolf C, Fitzpatrick H, Becker C, Smith J, Wood C Birth Defects Res. 2023; 115(16):1513-1533.
PMID: 37530699 PMC: 11253831. DOI: 10.1002/bdr2.2229.
Genetic Factors in Nonsyndromic Orofacial Clefts.
Khan M, Cs P, Srinath N Glob Med Genet. 2021; 7(4):101-108.
PMID: 33693442 PMC: 7938794. DOI: 10.1055/s-0041-1722951.
Deregulated Adhesion Program in Palatal Keratinocytes of Orofacial Cleft Patients.
Mammadova A, Carels C, Zhou J, Gilissen C, Helmich M, Bian Z Genes (Basel). 2019; 10(11).
PMID: 31652793 PMC: 6895790. DOI: 10.3390/genes10110836.